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Results: There were no signiﬁcant differences in age, sex, blood pressure, heart rate or
LVEF between the AS patients and controls. The LV mass index was dramatically
higher in AS patients than controls (106.327.5 vs. 67.410.5 g/m2, P<0.001).
Comparing with healthy controls, AS patients had signiﬁcantly lower circulating
levels of miR-1 (0.557 (0.202-0.711) vs. 0.979 (0.785-1.242), P<0.001), miR-133
(0.543 (0.469-0.651) vs. 0.947 (0.749-1.436), P<0.001) and miR-378 (0.560 (0.517-
0.736) vs. 0.944 (0.627-1.610), P<0.001). In the AS group, patients with LVH had
signiﬁcantly lower miR-378 (0.539 (0.515-0.629) vs. 0.624 (0.549-0.903), P¼0.022)
but not miR-1 and miR-133 compared with those without LVH. Linear regression
analysis showed circulating miR-378 had strong correlation with left ventricular mass
index (r¼0.283, P¼0.002) and logistic regression showed that lower miR-378 was an
independent predictor for LVH in patients with AS (P¼0.037, OR 4.110, 95% CI
1.086-15.558).
Conclusions: Circulating levels of miR-1, miR-133 and miR-378 were decreased in
AS patients, and miR-378 predicts LVH independent of the pressure gradient. Further
prospective investigations are needed to elucidate whether these circulating miRs
affect clinical outcome.
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Objectives: To present the clinical, echocardiographic, and hemodynamic proﬁle of
adult patients with MS who have undergone percutaneous transseptal mitral com-
missurotomy from 2010 to 2013 at the Philippine General Hospital.
Methods: We conducted a retrospective study of all adults with MS who underwent
PTMC from 2010-2013. Data were extracted using a standard data collection form.
A successful PTMC or a favorable outcome is deﬁned as a post- procedural hemo-
dynamic study of a mitral valve area (MVA) >1.5cm2 and/or a mean transmitral
gradient < 5mmHg. Other outcomes measured in this study were the development or
worsening of mitral regurgitation measured by hemodynamic studies, in-hospital
death, and post-procedural 2D echocardiography measurements of MVA > 1.5cm2
and mean mitral gradient <5 mmHg. Simple logistic regression was used to determine
the predictors of an unfavorable outcome after PTMC.
Results: 104 patients with a mean age of 38 years old, predominantly female, were
included. Majority had congestive heart failure functional class II and severe MS with
a mean Wilkin’s score of 7.9 by echocardiography. A successful PTMC was achieved
in 89%. Having a “repeat PTMC” (ie. PTMC for the second time) was associated with
an increased risk of developing an unfavorable outcome or failed PTMC [(OR 7.62,
CI 1.73-33.6)]. Moderate to severe or worsening of prior mitral regurgitation deter-
mined by hemodynamic studies developed in 3%. In-hospital mortality occurred in
3%. Pre- procedural hypotension (BP < 90/60) was associated with increased risk of
developing a new or worsening MR [OR 25.6, CI 1.28-516)] or death [OR 29 (CI
1.74-871)]. An MVA >1.5cm2 was achieved in 77% and 81% of patients measured by
2D echocardiogram and hemodynamic studies, respectively. A mean transmitral
gradient of < 5mmHg was achieved in 60% and 63% measured by 2D echocardio-
gram and hemodynamic studies, respectively.
Conclusions: The typical clinical proﬁle of a patient undergoing PTMC at PGH was a
middle-aged female with minimal co- morbidities, CHF functional class II from severe
MS. We described the clinical proﬁle and predictors of outcomes in patients who have
undergone PTMC in our center. Overall outcomes were excellent, but prospective
studies are recommended to evaluate hard outcomes such as functional capacity and
long-term mortality.
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Objectives: Small conductance calcium activated potassium channels (SK) were
found closely related to Atrial Fibrillation (AF). Dronedarone is recently used for the
patients with paroxysmal AF or after conversion of persistent AF. The purpose of this
study was to conﬁrm the inhibitory effects of dronedarone on SK as one of the potent
treated targets in patients with AF.
Methods: The right atrial appendages were obtained from 21 patients with sinus rate
(SR) and 18 patients with chronic AF (CAF). Single myocytes were isolated by
enzymatic dissociation with two-step method. The ionic currents were recorded using
whole-cell Conventional patch clamp techniques.
Results: The SK channels in patients atrial were sensitive to intracellular calcium, but
voltage-independent.Similar to amiodarone, dronedarone showed a concentration-
dependent inhibitory manner on SK channels current. In patients with SR, drone-
darone and amiodarone inhibited the SK channel current with IC50 values of 0.23 and
6.37 microM, respectively, which were close to their therapeutic concentrations. In
patients with CAF, the IC50 values were 0.09 microM with dronedarone and 2.1
microM with amiodarone.The inhibitory effects of dronedarone on SK channels wereJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cpotently in CAF than in SR. Compared with amiodarone, dronedarone showed more
effective inhibition on SK channels, especially during in patients with CAF.
Conclusions: Dronedarone exhibits strongly inhibitory effects on SK channels during
in patients with CAF, which might be one of treated targets of dronedarone for the
management of AF.
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Objectives: To investigate the value of the echocardiography in pre-operative,
intraoperative, and postoperative transcatheter aortic valve implantation (TAVI).
Methods: This study included 43 patients (27 males; 16 females; average ages was
747.2 years) with severe aortic valve stenosis who underwent successful TAVI in
our hospital. The anatomy of the aortic valve, aortic annulus, ventricular function and
other concerns were assessed by transthoracic echocardiography (TTE) one week
before TAVI and also by transesophageal echocardiography (TEE) during TAVI.
After the deployment of the prosthesis, TEE was used to ensure the position/stability
of prosthesis, severity and mechanism of aortic regurgitation (AR), and to assess
complications. One week post TAVI, TTE is sufﬁcient to check the prosthesis,
quantify the AR, and evaluate the changes of the ventricular function and left ven-
tricular mass.
Results: The aortic annulus dimension (AAD) measured by RT 3D-TEE was larger
and measured by 2D TEE, with no statistically signiﬁcant difference. But the AAD
measured by TTE was smaller than by RT 3D-TEE and 2D-TEE, with signiﬁcant
difference. None of the patients had cardiac tamponade and aortic dissection during
TAVI. Compared with pre-TAVI, The maximum aortic valve velocity and mean aortic
pressure gradient was decreased signiﬁcantly after TAVI (5.20.5m/s vs.2.70.5 m/s,
6715 mmHg vs.165 mmHg, respectively, P<0.05). The left ventricular ejection
fraction measured by 3D TTE was increased (48.28.7% vs.52.07.5, P<0.05). And
the left ventricular mass was improved (165.547.7 g/m2 vs.144.039.2 g/m2,
P<0.05). No server AR and central AR was observed post-TAVI. 2.3% patients
presented with moderate paravalvular AR, 30.2% patients with mild paravalvular AR,
and 67.5% with trace or no paravalvular AR.
Conclusions: Echocardiography play an important role in pre-operative, intra-
operative, and postoperative TAVI.
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Objectives: This study aimed to evaluate the expression of Klotho protein, Fibroblast
growth factor 23 (FGF23) in degenerated heart valvular disease (DHVD) patients and
their role in valvular calciﬁcation.
Methods: 71 suspected DHVD hospitalized patients (aged 50 years) were enrolled
between August 2012 and April 2013. Patients were divided into with valvular
calciﬁcation (DHVD group) and without valvular calciﬁcation group (non-DHVD
group) according to transthoracic echocardiographic examination. Serum calcium,
phosphorus, iPTH, hs-CRP were detected. Klotho and FGF23 were detected by
ELISA. Patients were followed for death or recurrent hospital admission in 32 weeks.
Results: (1) There were 39 patients with DHVD. Patients in DHVD group were older
than those in non-DHVD group (73.8 vs 69.4 years, P¼0.03) . There were no sig-
niﬁcant differences in coronary heart disease, hypertension, diabetes and smoking
between DHVD group and non-DHVD group (P>0.05) .The levels of hs-CRP (19.06
mg/L vs 5.06 mg/L, P¼0.01) , FGF23 (85.43 pg/ml vs 11.82 pg/ml, P¼0.001) were
higher in DHVD group than that in non-DHVD group and the results were not
changed when stratiﬁed by age or glomerular ﬁltration rate. However, there were no
signiﬁcant differences in the levels of Klotho protein, calcium, phosphorus and iPTH
between DHVD group and non-DHVD group (all P > 0.05). (2) The survival rate
were higher in non-DHVD group than that in DHVD group (100% vs 86.5%,
P¼0.045) . Multivariate Cox regression model was used to analyze the association
between survival and clinical parameter, including age, hs-CRP, Klotho protein,
FGF23, GFR, Lp (a). The levels of hs-CRP, FGF23 were identiﬁed as independent
prognostic factors for survival (RR¼1.033, P¼0.004; RR¼1.007, P¼0.048,
respectively).
Conclusions: The levels of FGF23 and hs-CRP in patients with DHVD were sig-
niﬁcant higher than that in non-DHVD and associated with poor clinical outcome.
FGF23 may be involved in the process of the DHVD, and the mechanisms may be
independent of the FGF23/Klotho axis.
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